Journal ArticleOPEN ACCESS

Potential Roles for PD-1 Inhibition and Cabozantinib in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma

  • Hahn A
  • Pal S
  • Agarwal N
The Oncologist (2020) 25(3) 186-188
DOI: 10.1634/theoncologist.2019-0657
1Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This commentary discusses studies in metastatic non-clear cell renal cell carcinoma and provides suggestions for choosing between treatment with nivolumab and treatment with cabozantinib.

Cite

CITATION STYLE

APA

Hahn, A. W., Pal, S. K., & Agarwal, N. (2020). Potential Roles for PD-1 Inhibition and Cabozantinib in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma. The Oncologist, 25(3), 186–188. https://doi.org/10.1634/theoncologist.2019-0657

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free